Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Bodansky O. Reflections on biochemical aspects of human cancer. The Lucy Wortham James Lecture. Cancer. 1974 Feb;33(2):364–370. doi: 10.1002/1097-0142(197402)33:2<364::aid-cncr2820330210>3.0.co;2-3. [DOI] [PubMed] [Google Scholar]
- Gail M. H., Green S. B. A generalization of the one-sided two-sample Kolmogorov-Smirnov statistic for evaluating diagnostic tests. Biometrics. 1976 Sep;32(3):561–570. [PubMed] [Google Scholar]
- Haglund C., Lundin J., Kuusela P., Roberts P. J. CA 242, a new tumour marker for pancreatic cancer: a comparison with CA 19-9, CA 50 and CEA. Br J Cancer. 1994 Sep;70(3):487–492. doi: 10.1038/bjc.1994.332. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Kawa S., Tokoo M., Hasebe O., Hayashi K., Imai H., Oguchi H., Kiyosawa K., Furuta S., Homma T. Comparative study of CA242 and CA19-9 for the diagnosis of pancreatic cancer. Br J Cancer. 1994 Sep;70(3):481–486. doi: 10.1038/bjc.1994.331. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Pasanen P. A., Eskelinen M., Partanen K., Pikkarainen P., Penttilä I., Alhava E. A prospective study of serum tumour markers carcinoembryonic antigen, carbohydrate antigens 50 and 242, tissue polypeptide antigen and tissue polypeptide specific antigen in the diagnosis of pancreatic cancer with special reference to multivariate diagnostic score. Br J Cancer. 1994 Mar;69(3):562–565. doi: 10.1038/bjc.1994.102. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Roulston J. E. Limitations of tumour markers in screening. Br J Surg. 1990 Sep;77(9):961–962. doi: 10.1002/bjs.1800770903. [DOI] [PubMed] [Google Scholar]